Global and Indian generic companies are in a hurry to seek patents for drug in India. Majority of these applications are for process and composition patents. Teva, a Israel based company, Ranbaxy, India's largest drug maker and Eli-Lily, a US based research company are in the top list, filing 380, 225 and 86 drugs respectively. A total of 10,000 applications are received by the Indian patent office recently in this regard.
ITAG Business Solutions Ltd. would not be held responsible for any opinion generated from views expressed in the article. The article are of personal use of technical experts and not necessary use of the organisation.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.